- English
- Español
- Português
- русский
- Français
- 日本語
- Deutsch
- tiếng Việt
- Italiano
- Nederlands
- ภาษาไทย
- Polski
- 한국어
- Svenska
- magyar
- Malay
- বাংলা ভাষার
- Dansk
- Suomi
- हिन्दी
- Pilipino
- Türkçe
- Gaeilge
- العربية
- Indonesia
- Norsk
- تمل
- český
- ελληνικά
- український
- Javanese
- فارسی
- தமிழ்
- తెలుగు
- नेपाली
- Burmese
- български
- ລາວ
- Latine
- Қазақша
- Euskal
- Azərbaycan
- Slovenský jazyk
- Македонски
- Lietuvos
- Eesti Keel
- Română
- Slovenski
- मराठी
- Srpski језик
New Products
Sinae intermedia Factory
Sandoo anno 2009 stabilivit, copiam facultatis a R&D gubernatore ad scalam mercatoriam formavimus., inter API, anti-cancer, intermedia medicamenta antiviralia, oeconomiae subtilia, cibaria additiva, necnon clavis media mixtorum polypeptidorum in facie biopharmaceuticorum in mundus.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
- View as
Ethyl(2s,5r)-5-((benzyloxy)amino)piperidine-2-carboxylata oxalata.
Product Name:Ethyl(2s,5r)-5-((benzyloxy)amino)piperidine-2-carboxylata oxalater
Formulae hypotheticae: C17H24N2O7
Pondus hypotheticum: 368.39
CAS Registry Number: 1416134-48-9
![(2S) -5- [(Phenylmethoxy)imino] -2-piperidinecarboxylicum acidum ethyl niensis](/upload/6698/-2s-5-phenylmethoxy-imino-2-piperidinecarboxylic-acid-ethyl-ester_13275.gif "(2S) -5- [(Phenylmethoxy)imino] -2-piperidinecarboxylicum acidum ethyl niensis")
(2S) -5- [(Phenylmethoxy)imino] -2-piperidinecarboxylicum acidum ethyl niensis
Product Name:(2S)-5-
Formulae hypotheticae: C15H20N2O3
Molecular Weight:276.33
CAS Subcriptio Number:1416134-60-5
O, O'-di-tert-butyl-L-threonine acetatis
Product Name: O, O'-di-tert-butyl-L-threonine acetatis
Formulae hypotheticae: C12H25NO3.C2H4O2
Molecular pondus:291.38
CAS Subcriptio Number:5854-77-3
N-(5-Chloropyridin-2-yl) acidum oxalaMicum ethyl ester
Product Name:N
Formulae hypotheticae: C9H9ClN2O3
Molecular pondus:228.63
CAS Subcriptio Number:349125-08-2
![tert-Butyl [(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate](/upload/6698/tert-butyl-1r-2s-5s-2-amino-5-dimethylamino-carbonyl-cyclohexyl-carbamate_890555.gif "tert-Butyl [(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate")
tert-Butyl [(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate
Product Name: tert-Butyl [(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate
Formulae hypotheticae: C14H27N3O3
Molecular pondus:285.38
CAS Registry Number:365998-36-3
(R)-(-)-3-Quinuclidinol
Product Name:(R)-(-)-3-Quinuclidinol
Formulae hypotheticae: C7H13NO
pondus hypotheticum: 127.18
CAS Registry Number: 25333-42-0
Sandoo magnus intermedia fabrica et praebitus in Sinis est. Officina nostra in intermedia exportare et importare plus quam 10 annos posita est, et fructus nostri toto orbe terrarum operiuntur, ut Civitates Foederatae, Canada, Britanniarum Regnum, Franciae, etc., paulatim plus quam XX operiunt. terris per orbem.
